Hans K Hasselbalch

Hans K Hasselbalch

Clinical Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
101 - 110 out of 133Page size: 10
  1. 2021
  2. Published

    Retinal drusen in patients with chronic myeloproliferative blood cancers are associated with an increased proportion of senescent T cells and signs of an aging immune system

    Liisborg, C., Skov, V., Kjær, L., Hasselbalch, Hans Carl & Sørensen, Torben Lykke, 2021, In: Aging. 13, 24, p. 25763—25777

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Smoking impairs molecular response, and reduces overall survival in patients with chronic myeloproliferative neoplasms: A retrospective cohort study

    Sørensen, A. L., Knudsen, T. A., Skov, V., Kjær, L., Holm, N., Ellervik, Christina & Hasselbalch, Hans Carl, 2021, In: British Journal of Haematology. 193, 1, p. 83-92

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms

    Hasselbalch, Hans Carl, Elvers, M. & Schafer, A. I., 2021, In: Blood. 137, 16, p. 2152-2160 9 p.

    Research output: Contribution to journal › Review › Research › peer-review

  5. Published

    Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care

    Christensen, S. F., Scherber, R. M., Mazza, G. L., Dueck, A. C., Brochmann, N., Andersen, Christen Bertel L, Hasselbalch, Hans Carl, Mesa, R. A. & Geyer, H. L., 2021, In: BMC Cancer. 21, 1, 13 p., 691.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms

    Handlos Grauslund, J., Holmström, M. O., Jørgensen, N. G., Klausen, U., Weis-Banke, S. E., El Fassi, D., Schöllkopf, C., Clausen, M. B., Gjerdrum, L. M. R., Breinholt, M. F., Kjeldsen, J. W., Hansen, M., Koschmieder, S., Chatain, N., Novotny, G. W., Petersen, J., Kjær, L., Skov, V., Met, Ö., Svane, I. M. & 2 others, Hasselbalch, Hans Carl & Andersen, Mads Hald, 26 Feb 2021, In: Frontiers in Oncology. 11, 17 p., 637420.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Forhøjede blodcelletal og vaskulær sygdom med de myeloproliferative neoplasier som modelsygdomme

    Hasselbalch, Hans Carl, Knudsen, T. A., Sørensen, A. L., Christensen, S. F., Larsen, Morten Kranker, Bak, M., El Fassi, D., Cordua, S., Brabrand, M., Thomsen, G., Stentoft, J., Starklint, J., Ellervik, Christina, Wienecke, Troels, Bruun, Niels Eske, Eickhardt-Dalbøge, C. E., Kjær, L. & Skov, V., 18 Oct 2021, In: Ugeskrift for Laeger. 183, 42, 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. 2022
  9. Published

    Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine

    Gigoux, M., Holmström, M. O., Zappasodi, R., Park, J. J., Pourpe, S., Bozkus, C. C., Mangarin, L. M. B., Redmond, D., Verma, S., Schad, S., George, M. M., Venkatesh, D., Ghosh, A., Hoyos, D., Molvi, Z., Kamaz, B., Marneth, A. E., Duke, W., Leventhal, M. J., Jan, M. & 23 others, Ho, V. T., Hobbs, G. S., Knudsen, T. A., Skov, V., Kjær, L., Larsen, T. S., Hansen, D. L., Lindsley, R. C., Hasselbalch, Hans Carl, Grauslund, J. H., Lisle, T. L., Met, Özcan, Wilkinson, P., Greenbaum, B., Sepulveda, M. A., Chan, T., Rampal, R., Andersen, Mads Hald, Abdel-Wahab, O., Bhardwaj, N., Wolchok, J. D., Mullally, A. & Merghoub, T., 2022, In: Science Translational Medicine. 14, 649, eaba4380.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Clonal haematopoiesis of indeterminate potential and impaired kidney function—A Danish general population study with 11 years follow-up

    Larsen, Morten Kranker, Skov, V., Kjær, L., Møller-Palacino, N. A., Pedersen, R. K., Andersen, M., Ottesen, J. T., Cordua, S., Poulsen, Henrik Enghusen, Dahl, Morten, Knudsen, T. A., Eickhardt-Dalbøge, C. S., Koschmieder, S., Pedersen, K. M., Çolak, Y., Bojesen, Stig Egil, Nordestgaard, Børge, Stiehl, T., Hasselbalch, Hans Carl & Ellervik, Christina, 2022, In: European Journal of Haematology. 109, 5, p. 576-585 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Coronary artery- and aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms

    Solli, C. N., Chamat-Hedemand, S., Elming, H., Ngo, A., Kjær, L., Skov, V., Sørensen, A. L., Ellervik, Christina, Fuchs, A., Sigvardsen, P. E., Kühl, J. T., Kofoed, Klaus Fuglsang, Nordestgaard, Børge, Hasselbalch, Hans Carl & Bruun, Niels Eske, 2022, In: International Journal of Cardiology. 364, p. 112-118 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Genomic profiling of a randomized trial of interferon-a vs hydroxyurea in MPN reveals mutation-specific responses

    Knudsen, T. A., Skov, V., Stevenson, K., Werner, L., Duke, W., Laurore, C., Gibson, C. J., Nag, A., Thorner, A. R., Wollison, B., Hansen, D. L., Ellervik, C., Fassi, D. E., de Stricker, K., Ocias, L. F., Brabrand, M., Bjerrum, O. W., Overgaard, U. M., Frederiksen, M., Kristensen, T. K. & 12 others, Kruse, T. A., Thomassen, M., Mourits-Andersen, T., Severinsen, M. T., Stentoft, J., Starklint, J., Neuberg, D. S., Kjaer, L., Larsen, T. S., Hasselbalch, Hans Carl, Lindsley, R. C. & Mullally, A., 2022, In: Blood advances. 6, 7, p. 2107-2119 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...7 8 9 10 11 12 13 14 Next

ID: 2849472